Tocilizumab in COVID-19: finding the optimal route and dose.

Jain, Siddharth; Jain, Sanjay; Sharma, Shefali Khanna

Jain, Siddharth; Jain, Sanjay; Sharma, Shefali Khanna.

Afiliación

Jain S; Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
Jain S; Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
Sharma SK; Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.

Lancet Rheumatol ; 2(12): e738-e739, 2020 Dec.

Article en En | MEDLINE | ID: mdl-32964209

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Lancet Rheumatol Año: 2020 Tipo del documento: Article País de afiliación: India Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google